GRIFOLS, S.A. «...678910...» Página 6 de 34 desde 01/07/1988 hasta 07/12/2023 26/01/2018 08:27 GRIFOLS, S.A. Others on corporate transactions Acquisition of 51% of the share capital in Goetech LLC (MedKeeper). Número de registro: 260997 05/12/2017 11:49 GRIFOLS, S.A. Loans, credit lines and guarantees Grifols has obtained a new long-term loan with the European Investment Bank Número de registro: 259188 22/11/2017 17:42 GRIFOLS, S.A. Others on business performance and financial information Grifols inaugurates a plant in Brazil Número de registro: 258783 17/11/2017 17:31 GRIFOLS, S.A. R&D: new licenses, patents and registered trademarks Grifols has earned approvals from the U.S. Food and Drug Administration and from the European Medicines Agency Número de registro: 258667 16/11/2017 08:25 GRIFOLS, S.A. Information on dividends Details of the interim dividend on account of 2017 profit Número de registro: 258581 06/11/2017 08:24 GRIFOLS, S.A. R&D: new licenses, patents and registered trademarks Grifols informs that it has earned approval from the U.S. FDA for a new product: Fibrin Sealant (Human) Número de registro: 258231 Relacionado con 252988 del 07/06/2017 (07:39) 02/11/2017 08:24 GRIFOLS, S.A. Information on P&L Performance summary for the third quarter 2017 Número de registro: 258082 02/11/2017 08:22 GRIFOLS, S.A. Interim financial information La sociedad remite información sobre los resultados del tercer trimestre de 2017 Número de registro: 258081 30/10/2017 08:18 GRIFOLS, S.A. Information on dividends Approval of interim dividend on account of 2017 profit Número de registro: 257978 22/09/2017 08:26 GRIFOLS, S.A. R&D: new licenses, patents and registered trademarks Grifols has earned approval from the U.S. Food and Drug Administration for a liquid formulation of its alpha-1 antitrypsin as a replacement therapy to treat alpha-1 antitrypsin deficiency, a rare genetic disorder. Número de registro: 256616 Página 6 de 34 «...678910...»
